Antiretroviral dose reduction: good for patients and rollout

Lancet. 2014 Apr 26;383(9927):1442-1443. doi: 10.1016/S0140-6736(13)62556-8. Epub 2014 Feb 10.

Authors

Jens D Lundgren¹, Andrew Phillips²

Affiliations

¹ Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark. Electronic address: jens.lundgren@regionh.dk.
² Research Department of Infection and Population Health, University College London, London, UK.

PMID: 24522177
DOI: 10.1016/S0140-6736(13)62556-8

No abstract available

Publication types

Comment

MeSH terms

Alkynes
Anti-HIV Agents / administration & dosage*
Benzoxazines / administration & dosage*
Cyclopropanes
Female
HIV Infections / drug therapy*
Humans
Male
Reverse Transcriptase Inhibitors / administration & dosage*

Substances

Alkynes
Anti-HIV Agents
Benzoxazines
Cyclopropanes
Reverse Transcriptase Inhibitors
efavirenz